Mind Cure Health will be focus its psychedelics R&D on psilocybin, ketamine and ibogaine. The Company will pursue both pain-based and mental health applications.
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.
Psychedelics micro-dosing offers several key advantages over psychedelic drug applications centered around heavier dosages.
Aphria Inc., a global cannabis company, has announced that it will transfer its stock exchange listing from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market (Nasdaq).
CBN is poised to be the next cannabis trend. It could join the ranks of terpenes, cannabis for pets, or maybe even CBD.
A coalition of marijuana advocacy groups sent a letter to House leadership on Friday, asking that they incorporate language allowing the cannabis industry to access banking services in upcoming coronavirus relief legislation.
Sales of adult-use cannabis in Illinois totaled more than $37 million in April as recreational marijuana retailers enjoyed status as essential businesses in the face of the ongoing coronavirus pandemic. Officials with the Illinois Department of Financial and Professional Regulation (IDFPR) announced on Monday that preliminary figures for adult-use cannabis retail sales came to $37,260,497.89 in April, the fourth month of the state’s newly legal recreational marijuana industry.